<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="letter" xml:lang="EN"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Autoimmunity</journal-id><journal-id journal-id-type="publisher-id">gaut</journal-id><journal-title>Autoimmunity</journal-title><issn pub-type="ppub">0891-6934</issn><issn pub-type="epub">1607-842X</issn><publisher><publisher-name>Informa Healthcare</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">19005879</article-id><article-id pub-id-type="pmc">2637678</article-id><article-id pub-id-type="doi">10.1080/08916930802428114</article-id><article-categories><subj-group subj-group-type="heading"><subject>Letter to the Editor</subject></subj-group></article-categories><title-group><article-title>Rheumatoid Arthritis and Anti-Thyroid Antibodies</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Yavasoglu</surname><given-names>Irfan</given-names></name><xref ref-type="aff" rid="au1">1</xref></contrib><contrib contrib-type="author"><name><surname>Senturk</surname><given-names>Taskin</given-names></name><xref ref-type="aff" rid="au2">2</xref></contrib><contrib contrib-type="author"><name><surname>Coskun</surname><given-names>Adil</given-names></name><xref ref-type="aff" rid="au1">1</xref></contrib><contrib contrib-type="author"><name><surname>Bolaman</surname><given-names>Zahit</given-names></name><xref ref-type="aff" rid="au1">1</xref></contrib><aff id="au1"><label>1</label>Department of Internal Medicine, Medical School of Adnan Menderes University, Aydin, Turkey</aff><aff id="au2"><label>2</label>Department of Rheumatology, Medical School of Adnan Menderes University, Aydin, Turkey</aff></contrib-group><author-notes><corresp>Correspondence: I. Yavasoglu, Division of Internal Medicine, Medical Faculty, Adnan Menderes University, 09100 Aydin, Turkey. Tel: +90 256 212 0020 Fax: +90 256 214 6495 E-mail: <email>dr_yavas@yahoo.com</email></corresp></author-notes><pub-date pub-type="epub"><day>20</day><month>1</month><year>2009</year></pub-date><pub-date pub-type="ppub"><month>2</month><year>2009</year></pub-date><pub-date pub-type="pmc-release"><day>20</day><month>1</month><year>2009</year></pub-date><volume>42</volume><issue>2</issue><fpage>168</fpage><lpage>169</lpage><history><date date-type="received"><day>05</day><month>8</month><year>2008</year></date><date date-type="accepted"><day>22</day><month>8</month><year>2008</year></date></history><permissions><copyright-statement>&#x000a9; Informa Healthcare USA, Inc.</copyright-statement><copyright-year>2009</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0/"><p>This is an open access article distributed under the <ext-link ext-link-type="uri" xlink:href="http://www.informaworld.com/mpp/uploads/iopenaccess_tcs.pdf">Supplemental Terms and Conditions for iOpenAccess articles published in Informa Healthcare journals</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p></license></permissions></article-meta></front><body><p>Irfan Yava&#x0015f;o&#x0011f;lu 4.8.2008</p><p>Editor:</p><p>The article entitled &#x0201c;Anti-thyroid antibodies and thyroid dysfunction in rheumatoid arthritis (RA): prevalence and clinical value&#x0201d; written by Atzeni et al. [<xref ref-type="bibr" rid="b1">1</xref>] and published in one of the recent issues of your journal was quite interesting. Here, we would like to emphasize some points.</p><p>RA is a chronic inflammatory autoimmune disorder that affects approximately 0.5&#x02013;1% xof the population. According to general opinion systemic autoimmune disorders rarely exists with organ specific autoimmune disorders. Our study included 82 patients (67 females and 15 males) diagnosed as RA according to criteria of ARA as well as 47 healthy control subjects (31 females and 16 males). All participants' free thyroxine (fT4), free triiodothyronine (fT3), thyroid-stimulating hormone (TSH), thyroglobulin antibody (anti-Tg) and anti-peroxidase (anti-TPO) antibody titers were measured. Results of the RA patients were compared with the controls (<xref ref-type="table" rid="tbl1">Table I</xref>). The anti-TPO positivity were 15.9% (13 patients) in patients with RA and 2.6% in control group. The anti-Tg positivity were 12.3% (10 patients) in patients with RA and 1.8% in control group [<xref ref-type="bibr" rid="b2">2</xref>]. Other study (like Turkish population), the overall frequencies of thyroid antibodies were 11% in primary Sj&#x000f6;gren's syndrome, 7% in RA, 17% in secondary Sj&#x000f6;gren's syndrome, 8% in healthy controls, and 94% in autoimmune thyroiditis.</p><table-wrap id="tbl1" position="float"><label>Table I</label><caption><p>The thyroid test findings for RA and controls.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">RA (<italic>n</italic> = 82)</th><th align="center" rowspan="1" colspan="1">Control (<italic>n</italic> = 47)</th><th align="center" rowspan="1" colspan="1"><italic>p</italic>-value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">fT3 (1.82&#x02013;4.62 pg/ml)&#x022c6;</td><td align="center" rowspan="1" colspan="1">2.72 &#x000b1; 0.79</td><td align="center" rowspan="1" colspan="1">2.56 &#x000b1; 0.71</td><td align="char" char="." rowspan="1" colspan="1">&#x0003e;0.05</td></tr><tr><td align="left" rowspan="1" colspan="1">fT4(0.932&#x02013;1.71 ng/dl)&#x022c6;</td><td align="center" rowspan="1" colspan="1">1.21 &#x000b1; 0.29</td><td align="center" rowspan="1" colspan="1">1.19 &#x000b1; 0.28</td><td align="char" char="." rowspan="1" colspan="1">&#x0003e;0.05</td></tr><tr><td align="left" rowspan="1" colspan="1">TSH (0.270&#x02013;4.2 IU/ml)&#x022c6;</td><td align="center" rowspan="1" colspan="1">3.46 &#x000b1; 1.92</td><td align="center" rowspan="1" colspan="1">3.06 &#x000b1; 1.52</td><td align="char" char="." rowspan="1" colspan="1">&#x0003e;0.05</td></tr><tr><td align="left" rowspan="1" colspan="1">Anti-TPO (&#x0003e;40 IU/ml)&#x022c6;</td><td align="center" rowspan="1" colspan="1">85.69 &#x000b1; 106.83</td><td align="center" rowspan="1" colspan="1">43.16 &#x000b1; 132.23</td><td align="char" char="." rowspan="1" colspan="1">0.008</td></tr><tr><td align="left" rowspan="1" colspan="1">Anti-Tg (&#x0003e;40 IU/ml)&#x022c6;</td><td align="center" rowspan="1" colspan="1">58.2 &#x000b1; 83.9</td><td align="center" rowspan="1" colspan="1">24.19 &#x000b1; 36.74</td><td align="char" char="." rowspan="1" colspan="1">0.0004</td></tr></tbody></table><table-wrap-foot><fn id="tf1-1"><label>&#x022c6;</label><p>Normal value.</p></fn></table-wrap-foot></table-wrap><p>There was no difference for the frequency of the thyroid antibodies among the groups if patients with autoimmune thyroiditis were excluded [<xref ref-type="bibr" rid="b3">3</xref>]. Control group is important. Racial difference (even local) may exist between RA and anti-thyroid antibodies. In our area there is endemic goiter. Although rheumatoid factor (RF) is an autoantibody, in the current study we found no correlation between RF titer and duration of RA thyroid autoantibodies in RA patients (<italic>p</italic> &#x0003e; 0.05). We suggest that anti-thyroid autoantibodies are independent from the duration of RA and RF as there was not an apparent finding specific for a thyroid disorder in patients with RA in our study [<xref ref-type="bibr" rid="b2">2</xref>]. In conclusion, the anti-thyroid antibody positivity identified here might be due to a pathologic auto-immune response rather than demonstrating a thyroid disease. Thyroid function and anti-thyroid antibodies tests should be performed as part of the biochemical and immunological profile in RA patients.</p></body><back><ref-list><title>References</title><ref id="b1"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Atzeni</surname><given-names>F</given-names></name><name><surname>Doria</surname><given-names>A</given-names></name><name><surname>Ghirardello</surname><given-names>A</given-names></name><name><surname>Turiel</surname><given-names>M</given-names></name><name><surname>Batticciotto</surname><given-names>A</given-names></name><name><surname>Carrabba</surname><given-names>M</given-names></name><name><surname>Sarzi-Puttini</surname><given-names>P</given-names></name></person-group><article-title>Anti-thyroid antibodies and thyroid dysfunction in rheumatoid arthritis: Prevalence and clinical value</article-title><source>Autoimmunity</source><year>2008</year><volume>41</volume><fpage>111</fpage><lpage>115</lpage><pub-id pub-id-type="pmid">18176873</pub-id></citation></ref><ref id="b2"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Senturk</surname><given-names>T</given-names></name><name><surname>Yavasoglu</surname><given-names>I</given-names></name><name><surname>Coskun</surname><given-names>A</given-names></name><name><surname>Bolaman</surname><given-names>Z</given-names></name></person-group><article-title>Romatoid Artritli Hastalarda Tiroid Otoantikor Prevalans&#x00131;</article-title><source>Adnan Menderes &#x000dc;niversitesi T&#x00131;p Fak&#x000fc;ltesi Dergisi</source><year>2005</year><volume>6</volume><fpage>15</fpage><lpage>18</lpage></citation></ref><ref id="b3"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tunc</surname><given-names>R</given-names></name><name><surname>Gonen</surname><given-names>MS</given-names></name><name><surname>Acbay</surname><given-names>O</given-names></name><name><surname>Hamuryudan</surname><given-names>V</given-names></name><name><surname>Yazici</surname><given-names>H</given-names></name></person-group><article-title>Autoimmune thyroiditis and anti-thyroid antibodies in primary Sjogren's syndrome: A case-control study</article-title><source>Ann Rheum Dis</source><year>2004</year><volume>63</volume><fpage>575</fpage><lpage>577</lpage><pub-id pub-id-type="pmid">15082490</pub-id></citation></ref></ref-list><fn-group><fn><p>We did not receive any financial support, and this study has not been published in any journal.</p></fn></fn-group></back></article>